NorthStar Asset Management (New Jersey)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
NorthStar Asset Management (New Jersey)'s PFE Position: Q1 2026 in Review
NorthStar Asset Management (New Jersey) reduced its Pfizer (PFE) stake by 3.2% in Q1 2026, selling an estimated $7.38K and leaving 8,316 shares worth $234K. The position accounts for 0.11% of the portfolio, ranked #86.
NorthStar Asset Management (New Jersey) first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $351K in Q3 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- NorthStar Asset Management (New Jersey) held 8,316 shares of Pfizer worth $234K as of Q1 2026.
- NorthStar Asset Management (New Jersey) sold 277 Pfizer shares in Q1 2026, an estimated $7.38K.
- Pfizer made up 0.11% of NorthStar Asset Management (New Jersey)'s portfolio in Q1 2026, its #86 holding.
- NorthStar Asset Management (New Jersey) first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- NorthStar Asset Management (New Jersey)'s Pfizer position peaked at $351K in Q3 2024.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on NorthStar Asset Management (New Jersey)'s 13F filing for Q1 2026, filed 8 May 2026.